{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T19:26:00Z","timestamp":1773948360085,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.ejso.2018.07.050","type":"journal-article","created":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T12:44:34Z","timestamp":1532695474000},"page":"1532-1538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Impact of biological agents on the prevalence of chemotherapy associated liver injury (CALI): Multicentric study of patients operated for colorectal liver metastases"],"prefix":"10.1016","volume":"44","author":[{"given":"Catherine","family":"Hubert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerio","family":"Lucidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Weerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Dili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"Demetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Massart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Komuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5362-8764","authenticated-orcid":false,"given":"Julie","family":"Navez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Reding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Gigot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Sempoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2018.07.050_bib1","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2006.09.6305","article-title":"Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200","volume":"25","author":"Giantonio","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2018.07.050_bib2","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2018.07.050_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1634\/theoncologist.6-1-81","article-title":"Irinotecan plus fluorouracil\/leucovorin for metastatic colorectal cancer: a new survival standard","volume":"6","author":"Saltz","year":"2001","journal-title":"Oncologist"},{"key":"10.1016\/j.ejso.2018.07.050_bib4","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdh095","article-title":"Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer","volume":"15","author":"Rubbia-Brandt","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2018.07.050_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.surg.2009.01.004","article-title":"Prevalence and clinical relevance of pathological hepatic changes occurring after neoadjuvant chemotherapy for colorectal liver metastases","volume":"147","author":"Hubert","year":"2010","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2018.07.050_bib6","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","article-title":"Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases","volume":"24","author":"Vauthey","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2018.07.050_bib7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/SLA.0b013e31815774de","article-title":"Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy","volume":"247","author":"Nakano","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2018.07.050_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.sla.0000193603.26265.c3","article-title":"Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases","volume":"243","author":"Karoui","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2018.07.050_bib9","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.gassur.2003.09.012","article-title":"Impact of steatosis on perioperative outcome following hepatic resection","volume":"7","author":"Kooby","year":"2003","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.ejso.2018.07.050_bib10","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1478-3231.2007.01511.x","article-title":"Nodular regenerative hyperplasia: a deleterious consequence of chemotherapy for colorectal liver metastases?","volume":"27","author":"Hubert","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.ejso.2018.07.050_bib11","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1200\/JCO.2006.05.8156","article-title":"Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases","volume":"24","author":"Aloia","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2018.07.050_bib12","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/hpb.12047","article-title":"Sinusoidal obstruction syndrome (SOS) related to chemotherapy for colorectal liver metastases: factors predictive of severe SOS lesions and protective effect of bevacizumab","volume":"15","author":"Hubert","year":"2013","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.ejso.2018.07.050_bib13","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ejso.2008.12.013","article-title":"Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX\/FOLFOX therapy of colorectal cancer liver metastases","volume":"35","author":"Klinger","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2018.07.050_bib14","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/cncr.23099","article-title":"Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases","volume":"110","author":"Ribero","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2018.07.050_bib15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jhep.2017.02.031","article-title":"Reversibility of chemotherapy-related liver injury","volume":"0","author":"Vigan\u00f2","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.ejso.2018.07.050_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1245\/s10434-015-4533-0","article-title":"Nodular regenerative hyperplasia in patients undergoing liver resection for colorectal metastases after chemotherapy: risk factors, preoperative assessment and clinical impact","volume":"22","author":"Vigan\u00f2","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2018.07.050_bib17","series-title":"New classification of physical status. Anesthesiology","author":"Soliani","year":"1963"},{"key":"10.1016\/j.ejso.2018.07.050_bib18","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A\u00a0simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.ejso.2018.07.050_bib19","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/SLA.0b013e3181c79403","article-title":"Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome","volume":"251","author":"Soubrane","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2018.07.050_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2018.07.050_bib21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/bjs.6429","article-title":"Liver dysfunction and sepsis determine operative mortality after liver resection","volume":"96","author":"Capussotti","year":"2009","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2018.07.050_bib22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/bjs.7368","article-title":"Impact of bevacizumab on functional recovery and histology of the liver after resection of colorectal metastases","volume":"98","author":"Wicherts","year":"2011","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2018.07.050_bib23","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/hep.1840110512","article-title":"Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules","volume":"11","author":"Wanless","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.ejso.2018.07.050_bib24","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty\u00a0liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.ejso.2018.07.050_bib25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2307\/2986126","article-title":"Algorithm as 288: exact Smirnov two-sample tests for arbitrary distributions","volume":"43","author":"Nikiforov","year":"1994","journal-title":"Appl Stat"},{"key":"10.1016\/j.ejso.2018.07.050_bib26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1207\/S15327906347-387","article-title":"Factor analysis of ordinal variables: a comparison of three approaches","volume":"36","author":"J\u00f6reskog","year":"2001","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/j.ejso.2018.07.050_bib27","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2307\/2531405","article-title":"Confidence intervals for the ratio of two binomial proportions","volume":"40","author":"Koopman","year":"1984","journal-title":"Biometrics"},{"key":"10.1016\/j.ejso.2018.07.050_bib28","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2559.2010.03511.x","article-title":"Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented\u00a0by bevacizumab in patients with hepatic colorectal metastasis","volume":"56","author":"Rubbia-Brandt","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.ejso.2018.07.050_bib29","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0016-5085(03)01056-4","article-title":"Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition","volume":"125","author":"Deleve","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejso.2018.07.050_bib30","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/sj.bmt.1703061","article-title":"Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation","volume":"27","author":"Iguchi","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ejso.2018.07.050_bib31","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jamcollsurg.2005.01.024","article-title":"Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases","volume":"200","author":"Fernandez","year":"2005","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.ejso.2018.07.050_bib32","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/PAS.0b013e3181dc242c","article-title":"Chemotherapy-induced liver injury in metastatic colorectal cancer: semiquantitative histologic analysis of 334 resected liver specimens shows that vascular injury but not steatohepatitis is associated with preoperative chemotherapy","volume":"34","author":"Ryan","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2018.07.050_bib33","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.surg.2008.12.002","article-title":"Risk factors for chemotherapy-associated liver injuries: a multivariate analysis of a group of 146 patients with colorectal metastases","volume":"145","author":"Brouquet","year":"2009","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2018.07.050_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00595-010-4414-x","article-title":"Sinusoidal obstruction syndrome compromises liver regeneration in patients undergoing two-stage hepatectomy with portal vein embolization","volume":"41","author":"Narita","year":"2011","journal-title":"Surg Today"},{"key":"10.1016\/j.ejso.2018.07.050_bib35","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/archsurg.2012.1867","article-title":"Prospective evaluation of accuracy of liver biopsy findings in the identification of chemotherapy-associated liver injuries","volume":"147","author":"Vigan\u00f2","year":"2012","journal-title":"Arch Surg"},{"key":"10.1016\/j.ejso.2018.07.050_bib36","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1159\/000184734","article-title":"\u201cLiver first\u201d approach in the treatment of colorectal cancer with synchronous liver metastases","volume":"25","author":"Mentha","year":"2008","journal-title":"Dig Surg"},{"key":"10.1016\/j.ejso.2018.07.050_bib37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1477-2574.2012.00607.x","article-title":"A\u00a0systematic review of two-stage hepatectomy in patients with initially unresectable colorectal liver metastases","volume":"15","author":"Lam","year":"2013","journal-title":"HPB (Oxford)"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798318312526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798318312526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:28:11Z","timestamp":1760059691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798318312526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0748798318312526"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2018.07.050","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of biological agents on the prevalence of chemotherapy associated liver injury (CALI): Multicentric study of patients operated for colorectal liver metastases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2018.07.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}